Sodium in PDB 7zzt: Ligand Binding to HDAC2
Enzymatic activity of Ligand Binding to HDAC2
All present enzymatic activity of Ligand Binding to HDAC2:
3.5.1.98;
Protein crystallography data
The structure of Ligand Binding to HDAC2, PDB code: 7zzt
was solved by
A.Cleasby,
D.Tisi,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
48.39 /
1.56
|
Space group
|
P 21 21 21
|
Cell size a, b, c (Å), α, β, γ (°)
|
92.208,
98.023,
139.275,
90,
90,
90
|
R / Rfree (%)
|
14.8 /
17.3
|
Other elements in 7zzt:
The structure of Ligand Binding to HDAC2 also contains other interesting chemical elements:
Sodium Binding Sites:
The binding sites of Sodium atom in the Ligand Binding to HDAC2
(pdb code 7zzt). This binding sites where shown within
5.0 Angstroms radius around Sodium atom.
In total 3 binding sites of Sodium where determined in the
Ligand Binding to HDAC2, PDB code: 7zzt:
Jump to Sodium binding site number:
1;
2;
3;
Sodium binding site 1 out
of 3 in 7zzt
Go back to
Sodium Binding Sites List in 7zzt
Sodium binding site 1 out
of 3 in the Ligand Binding to HDAC2
 Mono view
 Stereo pair view
|
A full contact list of Sodium with other atoms in the Na binding
site number 1 of Ligand Binding to HDAC2 within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Na603
b:21.9
occ:1.00
|
O
|
A:VAL198
|
2.3
|
20.7
|
1.0
|
O
|
A:PHE192
|
2.3
|
19.8
|
1.0
|
O
|
A:HOH817
|
2.4
|
19.6
|
1.0
|
O
|
A:THR195
|
2.4
|
21.5
|
1.0
|
O
|
A:HOH823
|
3.1
|
28.4
|
1.0
|
C
|
A:PHE192
|
3.5
|
18.9
|
1.0
|
C
|
A:VAL198
|
3.5
|
19.0
|
1.0
|
C
|
A:THR195
|
3.6
|
21.2
|
1.0
|
O
|
A:TYR227
|
3.6
|
19.7
|
1.0
|
CB
|
A:TYR227
|
3.7
|
20.7
|
1.0
|
CB
|
A:PHE192
|
4.0
|
17.0
|
1.0
|
N
|
A:THR195
|
4.1
|
22.0
|
1.0
|
C
|
A:TYR227
|
4.2
|
19.3
|
1.0
|
CG2
|
A:THR195
|
4.2
|
21.5
|
1.0
|
CA
|
A:PHE192
|
4.3
|
17.5
|
1.0
|
N
|
A:TYR193
|
4.4
|
19.2
|
1.0
|
C
|
A:TYR193
|
4.4
|
20.9
|
1.0
|
CA
|
A:TYR193
|
4.4
|
19.6
|
1.0
|
CA
|
A:THR195
|
4.4
|
23.0
|
1.0
|
O
|
A:TYR193
|
4.5
|
20.8
|
1.0
|
N
|
A:MET199
|
4.5
|
18.1
|
1.0
|
CA
|
A:MET199
|
4.5
|
18.4
|
1.0
|
CA
|
A:VAL198
|
4.5
|
18.5
|
1.0
|
N
|
A:VAL198
|
4.5
|
18.6
|
1.0
|
CA
|
A:TYR227
|
4.6
|
20.0
|
1.0
|
CA
|
A:GLY224
|
4.6
|
22.6
|
1.0
|
CB
|
A:VAL198
|
4.6
|
18.0
|
1.0
|
N
|
A:ASP196
|
4.6
|
22.2
|
1.0
|
O
|
A:GLY224
|
4.7
|
19.2
|
1.0
|
CA
|
A:ASP196
|
4.8
|
22.6
|
1.0
|
N
|
A:THR194
|
4.9
|
20.8
|
1.0
|
N
|
A:THR200
|
4.9
|
16.0
|
1.0
|
CG
|
A:TYR227
|
4.9
|
20.6
|
1.0
|
CB
|
A:THR195
|
4.9
|
22.6
|
1.0
|
N
|
A:ALA228
|
4.9
|
18.8
|
1.0
|
|
Sodium binding site 2 out
of 3 in 7zzt
Go back to
Sodium Binding Sites List in 7zzt
Sodium binding site 2 out
of 3 in the Ligand Binding to HDAC2
 Mono view
 Stereo pair view
|
A full contact list of Sodium with other atoms in the Na binding
site number 2 of Ligand Binding to HDAC2 within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Na603
b:20.0
occ:1.00
|
O
|
B:VAL198
|
2.3
|
18.0
|
1.0
|
O
|
B:PHE192
|
2.4
|
18.2
|
1.0
|
O
|
B:HOH881
|
2.4
|
16.8
|
1.0
|
O
|
B:THR195
|
2.5
|
20.1
|
1.0
|
O
|
B:HOH867
|
2.8
|
26.8
|
1.0
|
O
|
B:TYR227
|
3.5
|
20.9
|
1.0
|
C
|
B:PHE192
|
3.5
|
18.4
|
1.0
|
C
|
B:VAL198
|
3.5
|
18.1
|
1.0
|
C
|
B:THR195
|
3.7
|
20.4
|
1.0
|
CB
|
B:TYR227
|
3.7
|
20.5
|
1.0
|
CB
|
B:PHE192
|
4.0
|
16.8
|
1.0
|
C
|
B:TYR227
|
4.1
|
19.7
|
1.0
|
N
|
B:THR195
|
4.2
|
20.4
|
1.0
|
CG2
|
B:THR195
|
4.3
|
20.6
|
1.0
|
CA
|
B:PHE192
|
4.4
|
17.5
|
1.0
|
N
|
B:TYR193
|
4.4
|
18.2
|
1.0
|
C
|
B:TYR193
|
4.4
|
19.5
|
1.0
|
N
|
B:MET199
|
4.4
|
16.4
|
1.0
|
CA
|
B:TYR193
|
4.4
|
18.7
|
1.0
|
CA
|
B:MET199
|
4.4
|
18.1
|
1.0
|
O
|
B:TYR193
|
4.4
|
19.7
|
1.0
|
CA
|
B:VAL198
|
4.4
|
17.6
|
1.0
|
CA
|
B:THR195
|
4.5
|
21.2
|
1.0
|
N
|
B:VAL198
|
4.5
|
17.7
|
1.0
|
CA
|
B:TYR227
|
4.5
|
19.6
|
1.0
|
CB
|
B:VAL198
|
4.6
|
16.6
|
1.0
|
CA
|
B:GLY224
|
4.7
|
22.0
|
1.0
|
N
|
B:ASP196
|
4.7
|
20.8
|
1.0
|
O
|
B:GLY224
|
4.7
|
20.1
|
1.0
|
N
|
B:THR200
|
4.8
|
15.9
|
1.0
|
N
|
B:ALA228
|
4.9
|
18.7
|
1.0
|
CA
|
B:ASP196
|
4.9
|
21.7
|
1.0
|
N
|
B:THR194
|
4.9
|
20.2
|
1.0
|
CG
|
B:TYR227
|
4.9
|
21.2
|
1.0
|
CB
|
B:THR195
|
5.0
|
21.4
|
1.0
|
|
Sodium binding site 3 out
of 3 in 7zzt
Go back to
Sodium Binding Sites List in 7zzt
Sodium binding site 3 out
of 3 in the Ligand Binding to HDAC2
 Mono view
 Stereo pair view
|
A full contact list of Sodium with other atoms in the Na binding
site number 3 of Ligand Binding to HDAC2 within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
C:Na603
b:20.2
occ:1.00
|
O
|
C:VAL198
|
2.3
|
19.1
|
1.0
|
O
|
C:PHE192
|
2.3
|
16.7
|
1.0
|
O
|
C:THR195
|
2.4
|
19.6
|
1.0
|
O
|
C:HOH845
|
2.4
|
18.1
|
1.0
|
O
|
C:HOH799
|
3.0
|
30.9
|
1.0
|
C
|
C:PHE192
|
3.4
|
17.3
|
1.0
|
C
|
C:VAL198
|
3.5
|
19.7
|
1.0
|
C
|
C:THR195
|
3.6
|
19.5
|
1.0
|
O
|
C:TYR227
|
3.6
|
20.6
|
1.0
|
CB
|
C:TYR227
|
3.7
|
19.7
|
1.0
|
CB
|
C:PHE192
|
4.0
|
17.8
|
1.0
|
N
|
C:THR195
|
4.1
|
18.3
|
1.0
|
CG2
|
C:THR195
|
4.1
|
19.4
|
1.0
|
C
|
C:TYR227
|
4.2
|
20.0
|
1.0
|
CA
|
C:PHE192
|
4.3
|
16.5
|
1.0
|
CA
|
C:THR195
|
4.3
|
19.4
|
1.0
|
N
|
C:TYR193
|
4.3
|
16.9
|
1.0
|
C
|
C:TYR193
|
4.3
|
18.6
|
1.0
|
O
|
C:TYR193
|
4.4
|
18.5
|
1.0
|
CA
|
C:TYR193
|
4.4
|
17.4
|
1.0
|
CA
|
C:MET199
|
4.4
|
19.5
|
1.0
|
N
|
C:MET199
|
4.4
|
18.6
|
1.0
|
CA
|
C:VAL198
|
4.5
|
18.3
|
1.0
|
N
|
C:VAL198
|
4.5
|
19.1
|
1.0
|
CA
|
C:TYR227
|
4.6
|
20.0
|
1.0
|
CA
|
C:GLY224
|
4.6
|
19.8
|
1.0
|
N
|
C:ASP196
|
4.6
|
20.3
|
1.0
|
CB
|
C:VAL198
|
4.6
|
18.0
|
1.0
|
O
|
C:GLY224
|
4.7
|
20.1
|
1.0
|
CB
|
C:THR195
|
4.8
|
19.6
|
1.0
|
N
|
C:THR194
|
4.8
|
17.8
|
1.0
|
CA
|
C:ASP196
|
4.9
|
22.3
|
1.0
|
CG
|
C:TYR227
|
4.9
|
20.7
|
1.0
|
N
|
C:THR200
|
4.9
|
18.6
|
1.0
|
N
|
C:ALA228
|
4.9
|
19.8
|
1.0
|
|
Reference:
E.Tamanini,
S.Miyamura,
I.M.Buck,
B.D.Cons,
L.Dawson,
C.East,
T.Futamura,
S.Goto,
C.Griffiths-Jones,
T.Hashimoto,
T.D.Heightman,
S.Ishikawa,
H.Ito,
Y.Kaneko,
T.Kawato,
K.Kondo,
N.Kurihara,
J.M.Mccarthy,
Y.Mori,
T.Nagase,
Y.Nakaishi,
J.Reeks,
A.Sato,
P.Schopf,
K.Tai,
T.Tamai,
D.Tisi,
A.J.Woolford.
Fragment-Based Discovery of A Novel, Brain Penetrant, Orally Active HDAC2 Inhibitor. Acs Med.Chem.Lett. V. 13 1591 2022.
ISSN: ISSN 1948-5875
PubMed: 36262388
DOI: 10.1021/ACSMEDCHEMLETT.2C00272
Page generated: Wed Oct 9 10:21:41 2024
|